186 related articles for article (PubMed ID: 6548074)
1. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
[TBL] [Abstract][Full Text] [Related]
2. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
5. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
6. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
[TBL] [Abstract][Full Text] [Related]
7. Familial hypocalciuric hypercalcaemia: observations on vitamin D metabolism and parathyroid function.
Davies M; Adams PH; Berry JL; Lumb GA; Klimiuk PS; Mawer EB; Wain D
Acta Endocrinol (Copenh); 1983 Oct; 104(2):210-5. PubMed ID: 6314724
[TBL] [Abstract][Full Text] [Related]
8. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.
Hutchesson AC; Bundred NJ; Ratcliffe WA
Postgrad Med J; 1995 Jan; 71(831):28-31. PubMed ID: 7708588
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
10. Dynamic tests of parathyroid function for diagnosis of primary hyperparathyroidism in malignancy.
Ljunghall S; Benson L; Rastad J; Wide L; Akerström G
Clin Endocrinol (Oxf); 1987 Aug; 27(2):163-70. PubMed ID: 3117451
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of hypercalcemia. Significance of the determination of intact parathyroid hormone for differential diagnosis].
Blind E; Raue F; Zisterer A; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1990 Nov; 115(46):1739-45. PubMed ID: 2226185
[TBL] [Abstract][Full Text] [Related]
12. [Determination of plasma parathyroid hormone in the differential diagnosis of hypercalcemias associated with malignant tumors].
Gasser AB; Burckhardt P
Schweiz Med Wochenschr; 1978 Jul; 108(27):1031-4. PubMed ID: 663597
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol in dogs with hypercalcaemia.
Gerber B; Hauser B; Reusch CE
Vet Res Commun; 2004 Nov; 28(8):669-80. PubMed ID: 15609867
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia-lymphoma.
Johnston SR; Hammond PJ
Postgrad Med J; 1992 Sep; 68(803):753-5. PubMed ID: 1480540
[TBL] [Abstract][Full Text] [Related]
15. Primary hyperparathyroidism or hypercalcaemia of malignancy?
Birkeland KI; Gallefoss F; Olsson S; Haug E
Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
[TBL] [Abstract][Full Text] [Related]
16. Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia.
Ranganath L; Jamal H; Jones L; Goddard PF
J Clin Pathol; 1998 Mar; 51(3):257-8. PubMed ID: 9659276
[TBL] [Abstract][Full Text] [Related]
17. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
Schömig M; Ritz E
Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
[TBL] [Abstract][Full Text] [Related]
18. [Immobilisation hypercalcaemia. 1 case (author's transl)].
Baglin A; Goupil A; Lortat-Jacob A; Arfi S; Gueris J; Milhaud G; Benoit J
Nouv Presse Med; 1978 Feb; 7(6):453-5. PubMed ID: 634783
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolites in idiopathic infantile hypercalcaemia.
McGraw ME
Arch Dis Child; 1986 Dec; 61(12):1246. PubMed ID: 3813624
[No Abstract] [Full Text] [Related]
20. Intravenous calcitriol lowers serum calcium concentrations in uraemic patients with severe hyperparathyroidism and hypercalcaemia.
Hamdy NA; Brown CB; Kanis JA
Nephrol Dial Transplant; 1989; 4(6):545-8. PubMed ID: 2507976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
